Foley’s fifth annual study on the costs associated with the Sarbanes-Oxley act, revealed that while internal costs have gone down, other out-of-pocket costs such as audit fees, board compensation and legal fees have risen over the past year and on average external audit fees have increased 271 percent between fiscal years 2001 and 2006 for companies with under $1 billion in revenue. Paul Broude, a partner in Foley’s Boston office, was quoted about the study results in the article “Study: Sarbanes-Related Costs Remain on the Rise,” which appeared in the August 10th issue of Boston Business Journal. Regarding findings of the study, Broude stated “Survey respondents still see SOX as too restrictive and think there ought to be more risk-based audit tests. People feel it’s become an exercise to go through. Everyone understands it, but the question is, once you standardize everything, is it really creating the value people are looking for?”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”